Coffee Consumption May Mitigate the Risk for Acute Kidney Injury: Results From the Atherosclerosis Risk in Communities Study.
acute kidney injury
beverages
caffeine
coffee
incident AKI
Journal
Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
20
09
2021
revised:
15
04
2022
accepted:
25
04
2022
entrez:
11
7
2022
pubmed:
12
7
2022
medline:
12
7
2022
Statut:
epublish
Résumé
Coffee is one of the most frequently consumed beverages worldwide and has been found to have a wide assortment of health benefits. Although habitual coffee consumption is associated with a lower incidence of chronic kidney disease, an association between coffee and acute kidney injury (AKI) has not yet been revealed. In the Atherosclerosis Risk in Communities (ARIC) Study, a prospective cohort study of 14,207 adults aged 45 to 64 years, coffee consumption (cups/d) was assessed at a single visit via food frequency questionnaires and compared with incident AKI defined by hospitalization with an AKI-related International Classification of Diseases code. In ARIC, there were 1694 cases of incident AKI in a median of 24 follow-up years. Higher coffee consumption was associated with lower AKI risk versus no consumption (hazard ratio [HR] <1 cup/d: 0.92 [95% CI: 0.79-1.08]; 1 cup/d: 1.08 [95% CI: 0.94-1.24]; 2 to 3 cups/d: 0.83 [95% CI: 0.72-0.95]; >3 cups/d: 0.83 [95% CI: 0.71-0.96]; reference: never, Higher coffee intake was associated with a lower risk of incident AKI and could present an opportunity for cardiorenal protection through diet. Further evaluation of the physiological mechanisms underlying the cardiorenal protective effects of coffee consumption is necessary.
Identifiants
pubmed: 35812301
doi: 10.1016/j.ekir.2022.04.091
pii: S2468-0249(22)01369-9
pmc: PMC9263223
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1665-1672Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL159292
Pays : United States
Organisme : NHLBI NIH HHS
ID : L40 HL159798
Pays : United States
Informations de copyright
© 2022 International Society of Nephrology. Published by Elsevier Inc.
Références
Clin Sci (Lond). 2002 Nov;103(5):461-6
pubmed: 12401118
Med Sci (Paris). 2016 May;32(5):485-90
pubmed: 27225921
Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1052-60
pubmed: 25999212
Molecules. 2016 Jul 28;21(8):
pubmed: 27483219
J Am Coll Cardiol. 2021 Jun 15;77(23):2939-2959
pubmed: 34112321
Am J Clin Nutr. 2006 Oct;84(4):888-93
pubmed: 17023717
Am J Kidney Dis. 2018 Aug;72(2):214-222
pubmed: 29571833
Sci Rep. 2017 Dec 21;7(1):17979
pubmed: 29269877
Eur J Clin Nutr. 2019 Aug;73(8):1133-1140
pubmed: 30341433
Food Funct. 2021 Nov 1;12(21):10324-10355
pubmed: 34558584
Eur J Nutr. 2015 Feb;54(1):149-56
pubmed: 24740588
Food Chem Toxicol. 2007 Aug;45(8):1428-36
pubmed: 17376579
Mutat Res. 2010 Oct 13;692(1-2):42-8
pubmed: 20709087
J Am Soc Nephrol. 2016 Feb;27(2):371-9
pubmed: 26561643
Am J Clin Nutr. 2014 Sep;100(3):891-900
pubmed: 25057154
Food Funct. 2014 Aug;5(8):1695-717
pubmed: 24671262
Hypertension. 1993 Dec;22(6):847-52
pubmed: 8244516
Redox Biol. 2015;4:208-14
pubmed: 25613291
Mymensingh Med J. 2020 Oct;29(4):991-1000
pubmed: 33116107
Clin Sci (Lond). 1987 Jun;72(6):749-56
pubmed: 3297472
Oxid Med Cell Longev. 2017;2017:6193694
pubmed: 29104728
Mol Nutr Food Res. 2010 Dec;54(12):1722-33
pubmed: 20589860
Clin Exp Pharmacol Physiol. 2002 Jul;29(7):559-63
pubmed: 12060097
Diabetologia. 2009 Dec;52(12):2561-9
pubmed: 19727658
Am J Kidney Dis. 2013 May;61(5):649-72
pubmed: 23499048
Appl Physiol Nutr Metab. 2008 Dec;33(6):1269-83
pubmed: 19088789
Am J Kidney Dis. 2016 Dec;68(6):853-861
pubmed: 27519166
Mol Nutr Food Res. 2016 Mar;60(3):682-6
pubmed: 26632023
F1000Prime Rep. 2014 Sep 04;6:83
pubmed: 25343040